Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001615774-18-011318
Filing Date
2018-10-25
Accepted
2018-10-25 16:11:27
Documents
1
Effectiveness Date
2018-10-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10024
  Complete submission text file 0001615774-18-011318.txt   11066
Mailing Address 2049 CENTURY PARK EAST, SUITE 320 LOS ANGELES CA 90067
Business Address 3 DAVOL SQUARE, A301 PROVIDENCE RI 02903 310-424-1986
Tivorsan Pharmaceuticals, Inc. (Filer) CIK: 0001705703 (see all company filings)

EIN.: 770702642 | State of Incorp.: DE | Fiscal Year End: 1217
Type: D | Act: 33 | File No.: 021-324387 | Film No.: 181139020